Kava, the anxiolytic herb: back to basics to prevent liver injury?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2125.2010.03775.xPMID 21284704PMCID PMC3045554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flavokawain B, the hepatotoxic constituent from kava root, induces GSH‐sensitive oxidative stress through modulation of IKK/NF‐κB and MAPK signaling pathways

  2010cited by this paper
• Kava hepatotoxicity: pathogenetic aspects and prospective considerations

  2010cited by this paper
• Kava hepatotoxicity--a clinical review.

  2010cited by this paper
• Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.

  2009cited by this paper
• The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum

  2009cited by this paper
• Kava hepatotoxicity: a European view.

  2008cited by this paper
• Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases

  2008cited by this paper
• Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in vanuatu.

  2008cited by this paper
• The safety of kava: a regulatory perspective.

  2007cited by this paper
• A re-evaluation of kava (Piper methysticum).

  2007cited by this paper
• The quality of kava consumed in the South Pacific

  2006cited by this paper
• Toxicity of kava pyrones, drug safety and precautions--a case study.

  2003cited by this paper
• Kava extract for treating anxiety.

  2003cited by this paper
• Kava extracts: safety and risks including rare hepatotoxicity.

  2003cited by this paper
• Kava—the Unfolding Story: Report on a Work-in-Progress

  2002cited by this paper
• Kava: an overview.

  1992cited by this paper

• Phytotherapie bei psychischen Erkrankungen in medizinischen Leitlinien

  2022cites this paper
• Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

  2022cites this paper
• Application of Metabolomics in Emergency Phytochemical Poisoning and Remediation

  2020cites this paper
• Kava as a Clinical Nutrient: Promises and Challenges

  2020cites this paper
• The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials.

  2018cites this paper
• Herbal medicines in the treatment of psychiatric disorders: 10‐year updated review

  2018cites this paper
• Kava for Generalized Anxiety Disorder: A Review of Current Evidence

  2018cites this paper
• NSAIDs and Natural Products Interactions : Mechanism and Clinical Implications

  2017cites this paper
• Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions.

  2017cites this paper
• Herbal Anxiolytics with Sedative Actions

  2017cites this paper
• The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem.

  2016cites this paper
• Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism

  2016cites this paper
• Integrative and Complementary Medicine in Psychiatry

  2015cites this paper
• The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem.

  2015cites this paper
• Traditional preparation of Phaleria nisidai, a Palauan tea, reduces exposure to toxic daphnane-type diterpene esters while maintaining immunomodulatory activity.

  2015cites this paper
• A Closer Look at the Risks vs. Benefits of Kava (Piper methysticum)

  2015cites this paper
• Measuring the Chemical and Cytotoxic Variability of Commercially Available Kava (Piper methysticum G. Forster)

  2014cites this paper
• Anaphylaxis and anaesthesia - can treating a cough kill?

  2014cites this paper
• Nutrients and herbal supplements for mental health

  2014cites this paper
• An ethnobotanical, ecological and LC-MS-based chemometric investigation of Phaleria nisidai, a traditional adaptogen containing diterpene esters from Palau, Micronesia

  2014cites this paper
• Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind Study

  2013cites this paper
• Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence

  2013cites this paper
• Herbal hepatotoxicity: a critical review.

  2013cites this paper
• Contaminant Hepatotoxins as Culprits for Kava Hepatotoxicity – Fact or Fiction?

  2013cites this paper
• Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.

  2012cites this paper
• Constituents in kava extracts potentially involved in hepatotoxicity: a review.

  2011cites this paper
• Kava and Kava Hepatotoxicity: Requirements for Novel Experimental, Ethnobotanical and Clinical Studies Based on a Review of the Evidence

  2011cites this paper
• Proposal for a kava quality standardization code.

  2011cites this paper
• Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits.

  2011cites this paper
• Kava and the Risk of Liver Toxicity: Past, Current, and Future

  2011cites this paper
• Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence.

  2011cites this paper